Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) (Descending) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
55390-0491-01 55390-0491 Etoposide Etoposide Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Oct. 22, 2001 March 31, 2012 No Longer Used
55390-0453-01 55390-0453 Mitomycin Mitomycin Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Oct. 11, 2001 Oct. 31, 2012 No Longer Used
55390-0452-01 55390-0452 Mitomycin Mitomycin Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Sept. 28, 2001 Jan. 31, 2013 No Longer Used
55390-0451-01 55390-0451 Mitomycin Mitomycin Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Sept. 28, 2001 Nov. 30, 2012 No Longer Used
55390-0391-10 55390-0391 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 40.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 19, 2012 In Use
55390-0391-50 55390-0391 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 40.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 19, 2012 In Use
55390-0377-01 55390-0377 Octreotide Acetate Octreotide Acetate Hormonal Therapy Somatostatin Analog March 9, 2009 April 30, 2013 No Longer Used
55390-0376-10 55390-0376 Octreotide Acetate Octreotide Acetate Hormonal Therapy Somatostatin Analog March 9, 2009 Jan. 31, 2013 No Longer Used
55390-0375-10 55390-0375 Octreotide Acetate Octreotide Acetate Hormonal Therapy Somatostatin Analog March 9, 2009 April 30, 2013 No Longer Used
55390-0370-10 55390-0370 Topotecan Hydrochloride Topotecan Hydrochloride 4.0 mg/4mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Dec. 1, 2020 In Use

Found 10,000 results in 7 millisecondsExport these results